A Phase I Trial to Evaluate Safety and Tolerability of Abatacept followed by Subcutaneous Interleukin-2 Administration in Patients with Amyotrophic Lateral Sclerosis

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date11/18/21 → …